Findings of remote monitoring of implantable cardioverter defibrillators during the COVID‐19 pandemic
Autor: | Franck Molin, Isabelle Nault, Karine Roy, Hugo De Larochellière, Christian Steinberg, François Philippon, Louis Blier, Gilles O'Hara, Benoit Plourde, Jean-François Sarrazin, Jean Champagne |
---|---|
Rok vydání: | 2020 |
Předmět: |
Male
2019-20 coronavirus outbreak medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Cross-sectional study Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) implantable cardioverter defibrillators COVID‐19 Pandemic Devices Humans Telemetry Medicine In patient remote monitoring Aged Monitoring Physiologic business.industry Clinical events COVID-19 General Medicine Middle Aged Defibrillators Implantable Cross-Sectional Studies Emergency medicine Female Observational study Cardiology and Cardiovascular Medicine business |
Zdroj: | Pacing and Clinical Electrophysiology |
ISSN: | 1540-8159 0147-8389 |
DOI: | 10.1111/pace.14086 |
Popis: | Background Monitoring of cardiac implantable electronic devices was highly impacted by the COVID‐19 pandemic considering the high volume of in‐person visits for regular follow‐up. Recent recommendations highlight the important role of remote monitoring to prevent exposure to the virus. This study compared remote monitoring of implantable cardioverter defibrillators (ICDs) in patients whose in‐person annual visit was substituted for a remote monitoring session with patients who were already scheduled for a remote monitoring session. Methods This was a cross‐sectional observational study of 329 consecutive patients between 20 March and 24 April 2020. Group 1 included 131 patients whose in‐person annual visit was substituted for a remote monitoring session. Group 2 included 198 patients who underwent a remote monitoring session as scheduled in their usual device follow‐up. The time interval since the last in‐person visit was 13.3 ± 3.2 months in group 1 and 5.9 ± 1.7 months in group 2 (P .99). Conclusion Remote monitoring of ICDs is useful to identify clinical events and allows physicians to treat patients appropriately during the COVID‐19 pandemic regardless of the time interval since their last in‐person visit. It reduces significantly in‐person visit for regular follow‐up. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |